Radical irradiation and misonidazole in the treatment of advanced cervical carcinoma: Results of a phase II trial
- 1 October 1985
- journal article
- research article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 11 (10) , 1783-1787
- https://doi.org/10.1016/0360-3016(85)90032-x
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Clinical trials of radiosensitizers: What should we expect?International Journal of Radiation Oncology*Biology*Physics, 1984
- A randomized comparison of misonidazole sensitized radiotherapy plus BCNU and radiotherapy plus bcnu for treatment of malignant glioma after surgery; Preliminary results of an RTOG studyInternational Journal of Radiation Oncology*Biology*Physics, 1983
- Pharmacokinetic studies using multiple administration of RO 03–8799, a 2-nitroimidazole radiosensitizerInternational Journal of Radiation Oncology*Biology*Physics, 1982
- Cure rate estimation and long-term prognosis of uterine cervix carcinomaCancer, 1981
- Distribution and tumour cytotoxicity of the radiosensitizer misonidazole (Ro-07-0582) in C57 miceBritish Journal of Cancer, 1979
- The toxicity of the radiosensitizer misonidazole towards hypoxic cellsin vitro: a model for mouse and manThe British Journal of Radiology, 1978
- Clinical testing of the radiosensitizer Ro 07-0582: Experience with multiple dosesBritish Journal of Cancer, 1977
- Radiosensitizing and cytocidal effects on hypoxic cells of RO-07-0582, and repair of x-ray injury, in an experimental mouse tumourBritish Journal of Cancer, 1977